Skip to search.
 TSX Down 0.61% TSX Ventures Up 0.04%

Neuralstem, Inc. (CUR)

-NYSE MKT
1.54 Down 0.05(3.14%) May 29, 4:00PM EDT
|After Hours : 1.54 0.00 (0.00%) May 29, 4:24PM EDT
Add to Portfolio
Prev Close:1.59
Open:1.61
Bid:1.53 x 7600
Ask:1.54 x 3100
1y Target Est:4.75
Beta:2.76
Earnings Date:Aug 6 - Aug 10 (Est.)
Day's Range:1.53 - 1.61
52wk Range:1.52 - 4.81
Volume:759,850
Avg Vol (3m):1,081,040
Market Cap:139.12M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CURDown 3.14%139.12M
GERNUp 0.65%610.22M
STEMDown 2.44%71.47M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8,168.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.26
Quarterly EPS Est (Jun-15) :-0.06
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of regenerative medicine treatments based on its human neuronal stem cells and small molecule compounds. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback